Somatostatin Receptor 2 Expression Determined by Immunohistochemistry in Cold Thyroid Nodules Exceeds That of Hot Thyroid Nodules, Papillary Thyroid Carcinoma, and Graves' Disease


Sancak S., Hardt A., Singer J., Kloeppel G., Eren F. T. , GÜLLÜOĞLU M. B. , ...Daha Fazla

THYROID, cilt.20, sa.5, ss.505-511, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Konu: 5
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1089/thy.2009.0203
  • Dergi Adı: THYROID
  • Sayfa Sayıları: ss.505-511

Özet

Background: There is a plethora of partly contradictory reports on somatostatin receptor (SSTR) expression in thyroid tumors. Therefore, our goal was to systematically determine SSTR2 expression in benign cold thyroid nodules (CNs), hot thyroid nodules (HNs), papillary carcinomas (PCs), and Graves' disease (GD) in comparison with intraindividual control tissues by means of immunohistochemistry.